Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs — Stella

Recruiting

Back to First Episode Psychosis trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(3 sites)

United States

Henderson Behavioral Health, Lauderdale Lakes, Florida

InterAct of Michigan, Grand Rapids, Michigan

InterAct of Michigan, Kalamazoo, Michigan

Key details

Phase

Post-approval study

Sponsor

Northwell Health

Collaborators

National Institute of Mental Health (NIMH)

Enrollment target

~300 participants

Started

July 2020

Primary completion

November 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

15 Years – 40 Years

Last updated September 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov